Zn2+ and mPTP Mediate Endoplasmic Reticulum Stress Inhibition-Induced Cardioprotection Against Myocardial Ischemia/Reperfusion Injury

被引:31
|
作者
Wang, Guochen [1 ,2 ]
Huang, Hongping [3 ]
Zheng, Huan [2 ]
He, Yonggui [2 ]
Zhang, Yidong [2 ]
Xu, Zhelong [4 ]
Zhang, Liu [1 ,2 ]
Xi, Jinkun [2 ,4 ]
机构
[1] Hebei Med Univ, Hosp 3, Dept Surg, Shijiazhuang 050017, Peoples R China
[2] North China Univ Sci & Technol, Inst Heart, Tangshan 063000, Peoples R China
[3] Linyi Peoples Hosp, Dept Internal Med, Linyi 276034, Shandong, Peoples R China
[4] Tianjin Med Univ, Dept Physiol & Pathophysiol, Tianjin 300070, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Endoplasmic reticulum stress; Zn2+; Mitochondrial permeability transition pore; Cardioprotection; Ischemia/reperfusion injury; MITOCHONDRIAL PERMEABILITY TRANSITION; ISCHEMIA REPERFUSION INJURY; CARDIOVASCULAR-DISEASE; INDUCED APOPTOSIS; OXIDATIVE STRESS; OXIDANT DAMAGE; GROWTH-FACTOR; RAT HEARTS; ER STRESS; ZINC IONS;
D O I
10.1007/s12011-016-0707-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of this study was to determine whether Zn2+ is involved in endoplasmic reticulum (ER) stress inhibition-induced cardioprotection against ischemia/reperfusion (I/R) injury by modulation of the mitochondrial permeability transition pore (mPTP) opening. Isolated rat hearts were subjected to 30-min regional ischemia followed by 2 h of reperfusion. Expression of glucose regulated protein 78 (GRP 78 or BIP), an ER homeostasis marker, was not increased during ischemia but was increased upon reperfusion, indicating that ER stress was initiated upon reperfusion but not during ischemia. The ER stress inhibitor tauroursodeoxycholic acid (TUDCA) given at reperfusion resulted in a significant reduction of GRP78 expression 30 and 60 min after the onset of reperfusion, an effect that was reversed by the zinc chelator N,N,N',N'-tetrakis-(2-pyridylmethyl) ethylenediamine (TPEN). The immunofluorescence study also showed that the effect of TUDCA on GRP78 expression was reversed by TPEN. TUDCA reduced infarct size and this was reversed by the mPTP opener atractyloside, indicating that ER stress inhibition may induce cardioprotection by modulating the mPTP opening. Experiments with transmission electron microscopy and hematoxylin-eosin staining also revealed that TUDCA prevented endoplasmic reticulum and mitochondrial damages at reperfusion, which was blocked by TPEN. Exposure of cardiac H9c2 cells to H2O2 increased GRP 78 and GRP 94 expressions, suggesting that oxidative stress can induce ER stress. Cells treated with H2O2 showed a significant decrease in tetramethylrhodamine ethyl ester (TMRE) fluorescence, indicating that H2O2 triggers the mPTP opening. In contrast, TUDCA prevented the loss of TMRE fluorescence, the effect that was blocked by TPEN, indicating a role of Zn in the preventive effect of ER stress inhibition on the mPTP opening. In support, TUDCA significantly increased intracellular free zinc. These data suggest that reperfusion but not ischemia initiates ER stress and inhibition of ER stress protects the heart from reperfusion injury through prevention of the mPTP opening. Increased intracellular free Zn accounts for the cardioprotective effect of ER stress inhibition.
引用
收藏
页码:189 / 197
页数:9
相关论文
共 50 条
  • [1] Zn2+ and mPTP Mediate Endoplasmic Reticulum Stress Inhibition-Induced Cardioprotection Against Myocardial Ischemia/Reperfusion Injury
    Guochen Wang
    Hongping Huang
    Huan Zheng
    Yonggui He
    Yidong Zhang
    Zhelong Xu
    Liu Zhang
    Jinkun Xi
    Biological Trace Element Research, 2016, 174 : 189 - 197
  • [2] Zn2+and mPTP Mediate ERS Inhibition-induced Cardioprotection Against Ischemia/Reperfusion Injury
    Xi, Jinkun
    He, Yonggui
    Fei, Shuo
    Zheng, Huan
    Xu, Zhelong
    CIRCULATION, 2014, 130
  • [3] Inhibition of endoplasmic reticulum stress by neuregulin-1 protects against myocardial ischemia/reperfusion injury
    Fang, Shan-Juan
    Li, Peng-Yang
    Wang, Chun-Mei
    Xin, Yi
    Lu, Wei-Wei
    Zhang, Xiao-Xia
    Zuo, Song
    Ma, Chang-Sheng
    Tang, Chao-Shu
    Nie, Shao-Ping
    Qi, Yong-Fen
    PEPTIDES, 2017, 88 : 196 - 207
  • [4] Roles of Endoplasmic Reticulum Stress in NECA-Induced Cardioprotection against Ischemia/Reperfusion Injury
    Xing, Fengmei
    Han, Hui
    He, Yonggui
    Zhang, Yidong
    Jing, Liwei
    Xu, Zhelong
    Xi, Jinkun
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2017, 2017
  • [5] Ameliorative effect of sevoflurane on endoplasmic reticulum stress mediates cardioprotection against ischemia-reperfusion injury
    Liu, Ai-Jie
    Pang, Chun-Xia
    Liu, Guo-Qiang
    Wang, Shi-Duan
    Chu, Chun-Qin
    Li, Lin-Zhang
    Dong, Yan
    Zhu, De-Zhang
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2019, 97 (05) : 345 - 351
  • [6] Trichostatin A Ameliorates Myocardial Ischemia/Reperfusion Injury Through Inhibition of Endoplasmic Reticulum Stress-induced Apoptosis
    Yu, Ling
    Lu, Mengmeng
    Wang, Ping
    Chen, Xia
    ARCHIVES OF MEDICAL RESEARCH, 2012, 43 (03) : 190 - 196
  • [7] Roles of Zn2+ and mPTP in resveratrol-induced myocardial protection against endoplasmic reticulum stress
    HE Yi-fei
    FU Yu
    ZHAO Yang
    LIU Yu-lin
    XI Jin-kun
    中国药理学与毒理学杂志, 2019, (10) : 797 - 797
  • [8] Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress
    Li, Jinjie
    Zhao, Ying
    Zhou, Nan
    Li, Longyun
    Li, Kai
    JOURNAL OF DIABETES RESEARCH, 2019, 2019
  • [9] Globular Adiponectin Attenuates Myocardial Ischemia/Reperfusion Injury by Upregulating Endoplasmic Reticulum Ca2+-ATPase Activity and Inhibiting Endoplasmic Reticulum Stress
    Guo, Jia
    Bian, Yunfei
    Bai, Rui
    Li, Hong
    Fu, Minghuan
    Xiao, Chuanshi
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2013, 62 (02) : 143 - 153
  • [10] cFLIPL Alleviates Myocardial Ischemia-Reperfusion Injury by Inhibiting Endoplasmic Reticulum Stress
    Li, Yun Zhao
    Wu, Hui
    Liu, Di
    Yang, Jun
    Yang, Jian
    Ding, Jia Wang
    Zhou, Gang
    Zhang, Jing
    Zhang, Dong
    CARDIOVASCULAR DRUGS AND THERAPY, 2023, 37 (02) : 225 - 238